SCHEMBL5556723

SCHEMBL5556723

O=CC(=O)c1cccc(C(=O)O)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.64
▸ ALDH1A1 P00352 1/20 0.64
▸ MAPK1 P28482 1/20 0.64
▸ UNG P13051 1/20 0.59
▸ CA12 O43570 1/20 0.54
▸ CA1 P00915 1/20 0.54
▸ CA2 P00918 1/20 0.54
▸ CA6 P23280 1/20 0.54
▸ CA9 Q16790 1/20 0.54
▸ KMO O15229 1/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ HPGD P15428 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ P4HB P07237 1/20 0.49
▸ DAO P14920 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ NAPRT Q6XQN6 1/20 0.48
▸ FOLH1 Q04609 1/20 0.47
▸ AKR1C3 P42330 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL503007 0.91 TDP1 (0.68) TDP1ALDH1A1MAPK1UNGCA12
Isophthalic Acid SCHEMBL11135251 0.84 UNG (0.65) TDP1ALDH1A1UNGCA12CA1
Isophthalic Acid SCHEMBL28462260 0.83 CA12 (0.71) TDP1UNGCA12CA1CA2
Isophthalic Acid SCHEMBL147366 0.83 CA12 (0.71) TDP1UNGCA12CA1CA2
Isophthalic Acid SCHEMBL20500514 0.83 CA12 (0.71) TDP1UNGCA12CA1CA2
Isophthalic Acid SCHEMBL28756611 0.83 CA12 (0.71) TDP1UNGCA12CA1CA2
Isophthalic Acid SCHEMBL2512374 0.83 CA12 (0.71) TDP1UNGCA12CA1CA2
Isophthalic Acid SCHEMBL22462 0.83 CA12 (0.71) TDP1UNGCA12CA1CA2
Isophthalic Acid SCHEMBL23529435 0.82 UNG (0.63) TDP1ALDH1A1UNGCA12CA1
Isophthalic Acid SCHEMBL11530535 0.82 UNG (0.63) TDP1ALDH1A1UNGCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1474416-B1 DIHYDROBENZODIAZEPIN-2-ONE-DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS HOFFMANN LA ROCHE (CH) 2007-09-26 — — EP disclosed
US-6949542-B2 Dihydro-benzo[b][1,4]diazepin-2-one derivatives HOFFMAN-LA ROCHE INC. (US) 2005-09-27 — — US disclosed
EP-1474416-A1 DIHYDROBENZODIAZEPIN-2-ONE-DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2004-11-10 — — EP disclosed
US-20030166639-A1 Dihydro-benzo[b][1,4]diazepin-2-one derivatives F. HOFFMAN-LA ROCHE AG (CH) 2003-09-04 — — US disclosed
WO-2003066623-A1 DIHYDROBENZODIAZEPIN-2-ONE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2003-08-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166639-A1 Dihydro-benzo[b][1,4]diazepin-2-one derivatives CYP1B1, GRIN2B, CYP4B1 TDP1 1306/4885ALDH1A1 314/4885MAPK1 1664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback